[1] 王有全. 超声引导下聚桂醇硬化治疗单纯性肝囊肿初步研究. 实用肝脏病杂志, 2017, 20(6): 748-751. [2] Danza FM, Falcione M, Bordonaro V, et al. Minocycline hydrochloride as a soft sclerotizing agent for symptomatic simple renal and hepatic cysts. Eur Rev Med Pharmacol Sci, 2017, 21(2): 408-415. [3] Labib PL, Aroori S, Bowles M, et al. Differentiating simple hepatic cysts from mucinous cystic neoplasms: radiological features, cyst fluid tumour marker analysis and multidisciplinary team outcomes. Dig Surg, 2017, 34(1): 36-42. [4] Sawada N, Endo T, Mikami K, et al. Kidney injury due to ureteral obstruction caused by compression from infected simple hepatic cyst. Case Rep Gastroenterol, 2017, 11(2): 312-319. [5] Aksoy S, Erdil I, Hocaoglu E, et al. The role of diffusion-weighted magnetic resonance imaging in the differential diagnosis of simple and hydatid cysts of the liver. Niger J Clin Pract, 2018, 21(2): 212-216. [6] Vardakostas D, Damaskos C, Garmpis N, et al. Minimally invasive management of hepatic cysts: indications and complications. Eur Rev Med Pharmacol Sci, 2018, 22(5): 1387-1396. [7] Shao QQ, Zhao BB, Dong LB, et al. Surgical management of Zollinger-Ellison syndrome: classical considerations and current controversies. World J Gastroenterol, 2019:25(32):4673-4681. [8] Gaballa D, Moyer M. Thoughts of the safety and efficacy of EUS-guided cyst ablation with the use of lauromacrogol. Gastrointest Endosc, 2018, 87(5): 1367. [9] Tong KS, Hassan R, Gan J, et al. Simple hepatic cyst rupture exacerbated by anticoagulation. BMJ Case Rep, 2019;12(9):e230243. [10] 长蒙, 姜葵, 王邦茂, 等. 超声引导下无水乙醇与聚桂醇硬化治疗较大单纯性肝囊肿的临床疗效对比分析. 世界华人消化杂志, 2018, 26(24): 1463-1469. [11] Mizumoto Y, Mizuno S, Nakai Y, et al. Cholangitis complicated by infection of a simple hepatic cyst. Clin J Gastroenterol, 2018, 11(6): 493-496. [12] Chen AW, Liu SH, Huang YY, et al. Preliminary experience with more stable polidocanol foam in sclerotherapy of head and neck venous malformations. Dermatol Surg, 2018, 44(11): 1421-1426. [13] Eso Y, Furuta A, Takai A, et al. Ultrasound-guided microfoam sclerotherapy with polidocanol for symptomatic giant hepatic cyst: Initial experience. Hepatol Res, 2018, 48(12): 1055-1063. [14] Kitagawa A, Yamamoto T, Matsunaga N, et al. Polidocanol sclerotherapy combined with transarterial embolization using n-Butyl cyanoacrylate for extracranial arteriovenous malformations. Cardiovasc Intervent Radiol, 2018, 41(6): 856-866. [15] Lee JW, Stone ML, Porrett PM, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567(7747):249-252. [16] Chi HC, Tsai CY, Tsai MM, et al. Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases. J Biomed Sci, 2019:26(1):24. [17] Qin S, Liu Y, Ning H, et al. Eus-guided lauromacrogol ablation of insulinomas: a novel treatment. Scand J Gastroenterol, 2018, 53(5): 616-620. [18] 刘彩云, 臧福波. 超声引导下穿刺介入治疗肝囊肿的临床应用效果分析. 中国医疗器械信息, 2019, 25(16): 98-99. [19] Wijnands TF, Görtjes AP, Gevers TJ, et al. Efficacy and safety of aspiration sclerotherapy of simple hepatic cysts: a systematic review. Am J Roentgenol, 2017, 208(1): 201-207. [20] Van Aerts RMM, Kievit W, D'Agnolo HMA, et al. Lanreotide reduces liver growth in patients with autosomal dominant polycystic liver and kidney disease. Gastroenterology. 2019:157(2):481-491. |